These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 9491842
21. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia. Sidi V, Roilides E, Bibashi E, Gompakis N, Tsakiri A, Koliouskas D. J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982 [Abstract] [Full Text] [Related]
22. Nephrotoxicity of aminoglycosides, polypeptides and cephalosporins in cancer patients. Krcméry V, Fuchsberger P, Gocár M, Salát T, Bodnárová J, Sobota R, Koza I, Svec J. Chemotherapy; 1991 Aug; 37(4):287-91. PubMed ID: 1790727 [Abstract] [Full Text] [Related]
27. Impact of pharmacist intervention on preventing nephrotoxicity from vancomycin. Masuda N, Maiguma T, Komoto A, Haruki Y, Sugiyama T, Kondo S, Teshima D. Int J Clin Pharmacol Ther; 2015 Apr; 53(4):284-91. PubMed ID: 25740266 [Abstract] [Full Text] [Related]
28. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients. Chuma M, Makishima M, Imai T, Tochikura N, Suzuki S, Kuwana T, Sawada N, Komatsu T, Sakaue T, Kikuchi N, Yoshida Y, Kinoshita K. Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798 [Abstract] [Full Text] [Related]
29. Mild nephrotoxicity associated with vancomycin use. Downs NJ, Neihart RE, Dolezal JM, Hodges GR. Arch Intern Med; 1989 Aug; 149(8):1777-81. PubMed ID: 2764651 [Abstract] [Full Text] [Related]
30. Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy. Cimino MA, Rotstein C, Slaughter RL, Emrich LJ. Am J Med; 1987 Dec; 83(6):1091-7. PubMed ID: 3503577 [Abstract] [Full Text] [Related]
31. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity. Pritchard L, Baker C, Leggett J, Sehdev P, Brown A, Bayley KB. Am J Med; 2010 Dec; 123(12):1143-9. PubMed ID: 21183005 [Abstract] [Full Text] [Related]
35. Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment. Hirai T, Hanada K, Kanno A, Akashi M, Itoh T. Eur J Clin Pharmacol; 2019 Jun; 75(6):859-866. PubMed ID: 30770940 [Abstract] [Full Text] [Related]